Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer. Yilmaz F, Yasar S, Tatar OD, Yildirim HC, et al. BMC Cancer 2024;24:1218.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yilmaz F, Yasar S, Tatar OD, Yildirim HC, et al. Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer. BMC Cancer 2024;24:1218.
PMID: 39354432